During the past decade, Hathaway Medical Centre conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hathaway Medical Centre" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Gilead Sciences" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Artu Biologicals" with 1 trials sponsored and "George Medicines PTY Limited" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hathaway Medical Centre" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Alimentary Health Ltd" with 1 trials as a collaborator and "Medical Research Council Population Health Research Unit, CTSU, University of Oxford (academic lead)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Hathaway Medical Centre" are "Hypertension" (4 trials), "Diabetes Mellitus, Type 2" (2 trials), "Acute Respiratory Infection" (1 trials), "Allergic Rhinoconjunctivitis" (1 trials) and "Chronic Kidney Disease" (1 trials). Many other conditions were trialed in "Hathaway Medical Centre" in a lesser frequency.

Most popular intervention types in "Hathaway Medical Centre" are "Drug" (10 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Darusentan" (2 trials), "Placebo" (2 trials), "Amlodipine 2.5 mg/indapamide 1.25 mg" (1 trials), "Bifidobacterium infantis 35624" (1 trials) and "Darusentan Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hathaway Medical Centre" are 10 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hathaway Medical Centre". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Hathaway Medical Centre, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hathaway Medical Centre, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".